Buck Institute launches a new initiative to measure and extend human healthspan
The Buck Institute for Research on Aging today announced the launch of Healthspan Horizons, a new initiative designed to…
New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
Single prenatal exposure to fungicide linked to disease across 20 generations
A single exposure to a toxic fungicide during pregnancy can increase the risk of disease for 20 subsequent…
New food pyramid website has a chatbot skeptical of its own content
How trustworthy is the new U.S. food pyramid? It’s a mixed bag, according to the government website devoted…
Long-Term Keto Diet Risks Raise Questions for Metabolic Health
A long-term study published in Science Advances has found that while a ketogenic diet limited weight gain in…
3 Healthcare Threats That Will Soon Become Too Big To Solve
Healthcare faces three urgent threats that require a coordination solution getty Most industries enjoy a luxury that U.S.…
PFAS exposure increases gestational diabetes risk
A comprehensive review of nearly 130 studies shows the strongest evidence to date that “forever chemicals” are associated…
Urine-based microRNA clock predicts biological aging without a blood test
By reading aging signals shed into urine, scientists show that a simple, non-invasive test can estimate biological aging…
‘Our grandparents never ate these things’: Cardiologist says real, unprocessed food is a basic human right
Your health is the foundation of your overall wellbeing. If you are not healthy, your surroundings are not…
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
Stopping GLP-1 drugs before pregnancy leads to more weight gain
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…